Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.550
-0.230 (-4.81%)
Dec 2, 2025, 4:00 PM EST - Market closed
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
$2,941
Profits / Employee
$605,515
Market Cap
246.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 136 | 52 | 61.90% |
| Dec 31, 2023 | 84 | 27 | 47.37% |
| Dec 31, 2022 | 57 | -33 | -36.67% |
| Dec 31, 2021 | 90 | 14 | 18.42% |
| Dec 31, 2020 | 76 | -12 | -13.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABEO News
- 1 day ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead - Seeking Alpha
- 20 days ago - Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Here's Why Abeona Therapeutics Popped Higher Today - The Motley Fool
- 20 days ago - Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 25 days ago - Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel) - GlobeNewsWire
- 6 weeks ago - Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs - GlobeNewsWire